Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2018 · 10-Q
Revenue$551.52M$551.52M+10.3% vs Q1 2017 Net Income$656.80M$656.80M+5,196.8% vs Q1 2017 EPS Diluted$21.77$21.77+5,209.8% vs Q1 2017 Gross Profit$302,200,000+11.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow$40,346,000N/M Free Cash Flowderived$13,162,000N/M Margins · derivedGross margin54.8%+0.8 pt vs Q1 2017
Operating margin7.9%+2.7 pt vs Q1 2017
Net margin119.1%+116.6 pt vs Q1 2017
ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end